In addition, Porchia et al. demonstrated that OSU inhibits thyroid cancer cells motility (NPA, WRO and ARO cell lines) by inhibiting PDK1, but also directly inhibiting P21-activated kinase (PAK) by competing with ATP in the ATP binding site. The gene discussed is PDK1; the disease is thyroid gland carcinoma.